Merck announced on Thursday that the United Kingdom conditionally authorized the use of its antiviral COVID-19 pill, molnupiravir. The pharmaceutical company said that molnupiravir, developed with Ridgeback Biotherapeutics, had been…
Copyright © 2024 | WordPress Theme by MH Themes